ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant
–News Direct– ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with details of a supplier agreement with AstraZeneca PLC to develop an androgen receptor (AR) detection assay to…